Foundry Partners’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-199,620
| Closed | -$2.26M | – | 400 |
|
|
2019
Q4 | $2.26M | Sell |
199,620
-18,275
| -8% | -$207K | 0.09% | 252 |
|
|
2019
Q3 | $2.37M | Sell |
217,895
-13,050
| -6% | -$142K | 0.1% | 242 |
|
|
2019
Q2 | $2.16M | Sell |
230,945
-1,975
| -0.8% | -$18.5K | 0.09% | 253 |
|
|
2019
Q1 | $2.86M | Sell |
232,920
-55,030
| -19% | -$676K | 0.11% | 237 |
|
|
2018
Q4 | $3.41M | Sell |
287,950
-113,725
| -28% | -$1.35M | 0.15% | 205 |
|
|
2018
Q3 | $5.78M | Sell |
401,675
-23,515
| -6% | -$339K | 0.22% | 173 |
|
|
2018
Q2 | $6.34M | Sell |
425,190
-50
| -0% | -$745 | 0.26% | 161 |
|
|
2018
Q1 | $5.55M | Buy |
425,240
+3,875
| +0.9% | +$50.6K | 0.24% | 167 |
|
|
2017
Q4 | $5.31M | Sell |
421,365
-16,025
| -4% | -$202K | 0.22% | 174 |
|
|
2017
Q3 | $5.66M | Buy |
437,390
+24,400
| +6% | +$316K | 0.23% | 173 |
|
|
2017
Q2 | $6.13M | Buy |
412,990
+3,275
| +0.8% | +$48.6K | 0.25% | 135 |
|
|
2017
Q1 | $4.92M | Buy |
409,715
+55,900
| +16% | +$671K | 0.21% | 183 |
|
|
2016
Q4 | $4.88M | Buy |
353,815
+86,615
| +32% | +$1.2M | 0.21% | 181 |
|
|
2016
Q3 | $3.58M | Buy |
267,200
+3,275
| +1% | +$43.9K | 0.19% | 172 |
|
|
2016
Q2 | $2.84M | Buy |
263,925
+850
| +0.3% | +$9.15K | 0.16% | 215 |
|
|
2016
Q1 | $2.76M | Buy |
263,075
+80,110
| +44% | +$841K | 0.27% | 120 |
|
|
2015
Q4 | $2.16M | Buy |
+182,965
| New | +$2.16M | 0.18% | 159 |
|